AI-Powered Prostate Cancer Diagnostics

Fast, Accurate, and Personalised

Diagnexia and Artera bring the first AI multimodal risk stratification tool for localised prostate cancer to the UK. Providing rapid, reliable insights to clinicians and patients.

Order Now

A Partnership Transforming Cancer Diagnostics

Diagnexia’s expertise in digital pathology and AI-driven diagnostics

Artera’s cutting-edge AI technology and clinical validation

The first multimodal AI risk stratification tool recommended by NCCN in the USA​

"This partnership highlights the transformative potential of AI in revolutionising personalised cancer care. As the first and only global digital pathology service, Diagnexia has been at the forefront of digital innovation from the start. We see this new wave of digital biomarkers as a pivotal advancement, and by combining our expertise with Artera’s innovative technology, we aim to transform digital diagnostics services in the UK and beyond.”

- Donal O’Shea, CEO, Diagnexia​

request more information

‍‍

‍Key Benefits for Clinicians & Patients‍

Enhanced Risk Stratification
‍

Predicts 10-year risk of metastasis and prostate cancer specific mortality​

Therapy Guidance & Empowered Decision making

Identifies patients who will benefit from short term androgen deprivation therapy (ADT) with radiotherapy, helping doctors tailor treatment to individual needs

Fast & Accurate Results
‍

Uses standard biopsy slides leading to no testing delays, delivering results in hours instead of weeks
Request More Information
X
Register your interest in offering the ArteraAI Prostate Biopsy Assay to your patients
Sitemap
HomeSpeedSpeedSpeedSpeedExpertiseExpertiseExpertiseExpertiseEaseEaseEaseEaseNews & ResourcesNews & ResourcesNews & ResourcesNews & ResourcesContactContactContactContactRequest Consult
Follow Us
© Copyright Diagnexia 2025
Regulated by Care Quality Commission
Diagnexia UK Limited is regulated by Care Quality Commission in England for Diagnostic and Screening Procedures
Deciphex Inc. is Clinical Laboratory Improvement Amendments registered in USA
12